- American City Business Journals•11 days ago
The most Navidea Biopharmaceuticals Inc. could recover from the last of its legal battle with former lender CRG is $12 million – and the most it could lose is $7 million – after being forced to choose between pursuing a legal counterclaim or going out of business. Navidea's sale of North American rights to Lymphoseek, its first approved drug, to Cardinal Health Inc. for $83 million cash this month could not close until CRG released liens it placed on all of Navidea's assets. The lender, which had been pursuing a default claim and trying to seize Navidea's bank accounts since last April, released the liens only after Navidea agreed to a settlement requiring a promise not to pursue future claims against CRG.
- Zacks•15 days ago
Cardinal Health (CAH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- PR Newswire•17 days ago
Connecting Career Potential and Company Leadership Earned Cardinal Health Distinction from National Association for Female Executives
DUBLIN, Ohio, March 8, 2017 /PRNewswire/ -- Connecting career potential and company leadership, Cardinal Health was again recognized among the nation's best workplaces for female advancement as a Top Company for Executive Women by the National Association for Female Executives (NAFE). "The NAFE Top 60 Companies for Executive Women are the leaders in the U.S. that have moved women into top executive positions and created a culture where talented women are nurtured, promoted and thrive," says Betty Spence, president of NAFE. Cardinal Health was recognized for its work to help develop female entrepreneurs and executives both inside and outside its organization. NAFE specifically highlights the company's employee resource groups, access to formal mentoring, sponsorship and leadership programs, and a co-ed speakers' bureau that travels the country to promote gender partnership.
CAH : Summary for Cardinal Health, Inc. Common St - Yahoo Finance
Cardinal Health, Inc. (CAH)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Day's Range||80.83 - 81.58|
|52 Week Range||62.70 - 87.85|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||19.56|
|Dividend & Yield||1.80 (2.20%)|
|1y Target Est||N/A|